Antibody induction therapy for lung transplant recipients

Luit Penninga, Christian H Møller, Ida Elisabeth Irene Penninga, Martin Iversen, Christian Gluud, Daniel A Steinbrüchel

32 Citations (Scopus)


Lung transplantation has become a valuable and well-accepted treatment option for most end-stage lung diseases. Lung transplant recipients are at risk of transplanted organ rejection, and life-long immunosuppression is necessary. Clear evidence is essential to identify an optimal, safe and effective immunosuppressive treatment strategy for lung transplant recipients. Consensus has not yet been achieved concerning use of immunosuppressive antibodies against T-cells for induction following lung transplantation.
Original languageEnglish
JournalCochrane Database of Systematic Reviews
Pages (from-to)CD008927
Publication statusPublished - 2013


Dive into the research topics of 'Antibody induction therapy for lung transplant recipients'. Together they form a unique fingerprint.

Cite this